About Rovia
As pathfinders, we collaborate with sponsors through the critical process of trial site selection, activation, and management, ultimately leading toward new possibilities and successful trial outcomes.
Transformative Approaches in Clinical Trials
That’s where Rovia comes in. Study to study, phase to phase, patient to patient…Rovia stands at the cutting edge of clinical research.
Established in 2007, our company is driven by a commitment to exceptional patient care and scientific collaboration. Our team brings together skilled professionals from diverse backgrounds. We have a proven track record of working closely with sponsors, CROs, and investigators to ensure the precision of our study results through meticulous data collection and thorough analysis. Our efficient processes enable seamless communication within our research team. With clinical research sites spread across the southeastern U.S., including fully owned facilities and partnerships with independent providers, we are revolutionizing trial site selection and activation, and broadening access to underserved communities. This innovative approach not only improves patient care, but also enhances research predictability and delivers more successful outcomes.


Leadership
Members of our management group share a passion for clinical research and a commitment to provide both a positive experience for patients and unfailingly accurate, productive results for sponsors and investigators. Leading teams of world-class clinicians, technical experts, academicians and researchers, each of our senior executives is dedicated to improving the lives and health of others in keeping with Rovia’s mission.

Patricio Castillas
Chief Executive Officer
Patricio brings over 20 years of leadership experience in Healthcare across various sectors including pharma, med device, value-based primary care, pharmacy and DME. He earned a B.S. in Biology from Duke University and an M.B.A from Stanford University. He’s an alum of Eli Lilly, Johnson & Johnson. Patricio is passionate about expanding the access of breakthrough therapies to patients in order to increase quality of life, reduce disease burden and reduce the overall cost of healthcare. He enjoys tennis, golf, reading and spending time with his wife and two kids.

Derick Jaindl
Chief Financial Officer
Mr. Jaindl offers over 20 years of experience in organizational development, focusing on finance, strategic planning, and cross-functional team building. He earned a Master of Accounting from the University of Miami, an MBA from Drexel University, and a Bachelor’s in Finance from Babson College. A graduate of GE’s Financial Management and Six Sigma programs and a licensed CPA, Mr. Jaindl has played vital roles in expanding debt facilities, acquisitions, and business exits. His previous leadership positions include CFO at MobileHelp and roles at Mednax, Tyco International, and Comcast.
Our Brands
Rovia’s diverse portfolio features a collection of companies each specializing in different aspects of the clinical research industry. These brands aim to advance healthcare through innovative research methods, diverse patient engagement strategies, and technology integration. By leveraging their expertise, Rovia’s brands collaborate to enhance the clinical trial experience, streamline drug development, and address critical medical needs, ultimately contributing to the advancement of medical science and better patient outcomes.